Give internet users a choice of language, and the majority pick their own. Around 72% are more likely to buy when the information speaks their language, and roughly 40% won’t buy at all in a language they don’t. The moment
The world’s largest drug safety database, the WHO’s VigiBase, holds over 40 million adverse event reports contributed by more than 180 countries. The FDA’s FAERS system has accumulated over 28 million reports and receives more than 2 million new ones
When Mercedes-Benz first entered China, it chose a name that sounded almost perfect. Bensi, a close phonetic match for Benz. The trouble showed up only when Chinese consumers read the characters. The pronunciation worked, but the meaning came out as
Most companies don’t set out to juggle multiple translation vendors. It happens gradually. Marketing hires one agency for campaigns, the product team, another. Legal insists on a specialist for contracts, and customer support contracts freelancers for help articles. Within a
In 2009, HSBC launched a global campaign built around the slogan “Assume Nothing.” It was meant to convey that the bank made no assumptions about customers and worked to understand their individual needs. But when the slogan rolled out across
Most enterprises discover their CMS localization problem the same way: they implement a sophisticated content management system designed to streamline global workflows, launch it across multiple markets, and then watch costs explode. Companies invest in technology that works brilliantly for
A single mistranslation in a patent claim can invalidate years of work and billions in R&D investment. When it comes to pharmaceutical patents in global markets, protection is only as strong as its weakest translation, its most vulnerable jurisdiction, or
eBay entered China in 2004 with a dominant global platform, strong brand recognition, and significant financial backing. Within two years, they’d lost the market to local competitor Taobao and eventually shut down their Chinese marketplace entirely. eBay’s platform worked perfectly;
A single mistranslated word in a clinical trial protocol can delay regulatory approval by months, while inconsistent terminology across submissions can derail market access entirely. In life sciences, regulatory translation isn’t about converting words between languages, but about maintaining scientific
Most pharmaceutical companies expanding into the Asia-Pacific make the same mistake of treating APAC clinical trials like extensions of their Western operations, just with different languages. Then they wonder why regulatory submissions stall, patient recruitment collapses, and site performance varies
Companies managing content in multiple languages spend the majority of their localization budget fixing problems that shouldn’t exist, such as retranslating identical content, correcting terminology inconsistencies, and rushing updates that proper planning would have handled smoothly. This is localization management
Decentralized clinical trials are reshaping how pharmaceutical and biotech companies conduct research. Instead of requiring patients to visit physical trial sites, DCTs bring the trial to patients via telemedicine, home health visits, wearable devices, and remote monitoring. The approach offers
